Results 31 to 40 of about 3,908,577 (301)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

open access: yesEmerging Microbes and Infections, 2021
The emergence of Omicron/BA.1 has brought new challenges to fight against SARS-CoV-2. A large number of mutations in the Spike protein suggest that its susceptibility to immune protection elicited by the existing COVID-19 infection and vaccines may be ...
Li Zhang   +10 more
semanticscholar   +1 more source

De Novo generation of escape Variant-specific CD8+ T-Cell responses following Cytotoxic T-Lymphocyte escape in chronic Human Immunodeficiency Virus Type 1 Infection [PDF]

open access: yes, 2005
Human immunodeficiency virus type 1 (HIV-1) evades CD8+ T-cell responses through mutations within targeted epitopes, but little is known regarding its ability to generate de novo CD8+ T-cell responses to such mutants.
Allgaier, R.L.   +35 more
core   +1 more source

Preprint: Mutation Rate Evolution Drives Immune Escape In Mismatch Repair-Deficient Cancer

open access: yes, 2022
SUMMARY Mutation rate optimisation drives evolution and immune evasion of bacteria and lentiviral strains, including HIV. Whether evolving cancer lineages similarly adapt mutation rates to increase tumour cell fitness is unknown.
Daniel Hochhauser   +29 more
core   +1 more source

Extracellular vesicles in pancreatic cancer immune escape: Emerging roles and mechanisms

open access: yesPharmacological Research, 2022
Pancreatic cancer (PC) is the most lethal malignancy worldwide due to its delayed diagnosis and limited treatment options. Despite great progress in clinical trials of immunotherapies for various cancers, their effectiveness in PC is very low, indicating
Chunping Liu   +6 more
doaj   +1 more source

PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells.

open access: yesCancer Letters, 2023
Our previous research defined a novel metabolic cancer associated fibroblasts subset (meCAFs) enriched in loose-type pancreatic ductal adenocarcinoma (PDAC) and related toCD8+ T cells accumulation.
Weiyu Ge   +15 more
semanticscholar   +1 more source

Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10

open access: yesFrontiers in Immunology, 2020
Tumor immune escape is an important part of tumorigenesis and development. Tumor cells can develop a variety of immunosuppressive mechanisms to combat tumor immunity.
Shan-Shan Yin, Feng-Hou Gao
doaj   +1 more source

Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection

open access: yesCellular Oncology, 2023
Background Cancer is increasingly recognized as a metabolic disease, with evidence suggesting that oxidative phosphorylation (OXPHOS) plays a significant role in the progression of numerous cancer cells.
Xutong Qiu, Yi Li, Zhuoyuan Zhang
semanticscholar   +1 more source

Selection of neutralizing antibody escape mutants with type A influenza virus HA-specific polyclonal antisera: possible significance for antigenic drift [PDF]

open access: yes, 1997
Ten antisera were produced in rabbits by two or three intravenous injections of inactivated whole influenza type A virions. All contained haemagglutination-inhibition (HI) antibody directed predominantly to an epitope in antigenic site B and, in addition,
Cleveland, S. Matthew   +2 more
core   +1 more source

Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission

open access: yesReviews in Medical Virology, 2022
The first dominant SARS‐CoV‐2 Omicron variant BA.1 harbours 35 mutations in its Spike protein from the original SARS‐CoV‐2 variant that emerged late 2019.
L. Shrestha   +4 more
semanticscholar   +1 more source

Human monoclonal antibody combination against SARS coronavirus : synergy and coverage of escape mutants [PDF]

open access: yes, 2006
Background: Experimental animal data show that protection against severe acute respiratory syndrome coronavirus (SARS-CoV) infection with human monoclonal antibodies (mAbs) is feasible.
Peiris, Joseph S. M.   +73 more
core   +1 more source

Home - About - Disclaimer - Privacy